Back
Forte Biosciences Vs. NovaBay Pharmaceuticals Industry Stock Comparison
Buy
62
FBRX
Forte Biosciences
Last Price:
15.94
Seasonality Move:
-2.23%
Sell
28
NBY
NovaBay Pharmaceuticals
Last Price:
0.69
Seasonality Move:
-0.57%
Buy
62
Forte Biosciences (FBRX)
is a Buy
Is Forte Biosciences a Buy, Sell or Hold?
- The current Forte Biosciences [FBRX] share price is $16.00. The Score for FBRX is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
- FBRX is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
28
NovaBay Pharmaceuticals (NBY)
is a Sell
Is NovaBay Pharmaceuticals a Buy, Sell or Hold?
- The current NovaBay Pharmaceuticals [NBY] share price is $0.68. The Score for NBY is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
- NBY is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
FBRX Stock Price Chart
What is Forte Biosciences's stock price today?
-
The Forte Biosciences share price today is $16.00
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and FBRX is experiencing slight buying pressure.
NBY Stock Price Chart
What is NovaBay Pharmaceuticals's stock price today?
-
The NovaBay Pharmaceuticals share price today is $0.68
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NBY is experiencing selling pressure, which indicates risk of future bearish movement.
FBRX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.04 | Buy |
| Relative Strength Index (14 RSI): | 93.07 | Buy |
| Chaikin Money Flow: | 186326 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.86 - 9.54) | Buy |
| Bollinger Bands (100): | (0.73 - 7.43) | Buy |
NBY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.01 | Buy |
| Relative Strength Index (14 RSI): | 48.48 | Sell |
| Chaikin Money Flow: | -30586 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.61 - 0.75) | Buy |
| Bollinger Bands (100): | (0.28 - 1.42) | Sell |
FBRX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 9.29 | Buy |
| 20-day SMA: | 6.57 | Buy |
| 50-day SMA: | 5.97 | Buy |
| 200-day SMA: | 2.37 | Buy |
| 8-day EMA: | 10.73 | Buy |
| 20-day EMA: | 7.84 | Buy |
| 50-day EMA: | 6.06 | Buy |
| 200-day EMA: | 3.25 | Buy |
NBY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.71 | Sell |
| 20-day SMA: | 0.71 | Sell |
| 50-day SMA: | 0.66 | Buy |
| 200-day SMA: | 2.33 | Sell |
| 8-day EMA: | 0.71 | Sell |
| 20-day EMA: | 0.7 | Sell |
| 50-day EMA: | 0.73 | Sell |
| 200-day EMA: | 5.57 | Sell |
Forte Biosciences Earnings Growth & FBRX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $5.38 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.31 per share, and an increase next year of $11.01 per share.
NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $77.59 per share, and an increase next year of $2.44 per share.
Forte Biosciences Technical Analysis
| Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
NovaBay Pharmaceuticals Technical Analysis
| Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||